Unlabelled: A notable proportion of patient transfers in Ontario are from long-term care facilities for consultation of musculoskeletal (MSK) issues. These transfers are costly for patients and the healthcare system. This study evaluated the utility of a telemedicine MSK (TeleMSK) service for long-term care patients requiring an orthopaedic consultation.
Method: A cross-sectional study was used to assess TeleMSK from September 2018 to April 2019. Twenty-six long-term care facilities participated in this study, which included 32 long-term care patients assessed via TeleMSK and 27 telemedicine liaisons. The Telehealth Satisfaction Scale and the Telemedicine Usability Questionnaire (TUQ) surveys were used to evaluate the usefulness of the TeleMSK program.
Results: Patients and families rated voice (64.3%) and visual (71.4%) quality of TeleMSK to be excellent as well as the length of consultation (92.9%). A total of 78.6% of participants rated explanations from physicians to be excellent and 92.9% of the participants rated the carefulness, skillfulness, respect, and sensitivity of the attending physician to be excellent 85.7%. Patients felt privacy and confidentiality was maintained and respected throughout the consultation. Most telemedicine liaisons agreed that TeleMSK improved accessibility and productivity of consultations, and 81.5% of the telemedicine liaisons strongly agreed that they would use TeleMSK again in the future.
Conclusion: TeleMSK allowed for accessible, timely orthopaedic consultations without compromising the quality of patient care. Patients, families, and telemedicine liaisons rated their experience and the use of TeleMSK as excellent. Barrier to health care is an important issue in the long-term care population. TeleMSK is an excellent medium to close this gap.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188273 | PMC |
| http://dx.doi.org/10.5435/JAAOSGlobal-D-19-00128 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Machine Learning Predictions of Recovery in Bilingual Poststroke Aphasia: Aligning Insights With Clinical Evidence.
Stroke
January 2025
Center for Brain Recovery, Boston University, MA (M.J.M., E.C., M.S., M.R.-M., S.K.).
Background: Predicting treated language improvement (TLI) and transfer to the untreated language (cross-language generalization, CLG) after speech-language therapy in bilingual individuals with poststroke aphasia is crucial for personalized treatment planning. This study evaluated machine learning models to predict TLI and CLG and identified the key predictive features (eg, patient severity, demographics, and treatment variables) aligning with clinical evidence.
Methods: Forty-eight Spanish-English bilingual individuals with poststroke aphasia received 20 sessions of semantic feature-based naming treatment in either their first or second language.
Health care systems and policies for older adults in Nepal: new challenges for a low-middle income country.
Discov Public Health
December 2024
Present Address: Department of Global Health, Georgetown University School of Health, Washington, DC USA.
Background: Nepal, like other low- and middle-income countries, is experiencing a rapid increase in the number of older adults and the rate of aging in the population. This has increased the number of older adults with age-associated chronic illnesses, which in turn will escalate the demand for specialized healthcare and long-term care in Nepal. However, very little is known regarding the current healthcare system and health policies for older adults in Nepal.
View Article and Find Full Text PDFEfficacy analysis of rituximab in treating patients with primary membranous nephropathy dependent on calcineurin inhibitors.
Front Immunol
January 2025
Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Background: This study evaluated the efficacy of rituximab (RTX) in primary membranous nephropathy (PMN) patients with incomplete remission and drug dependence after long-term use of calmodulin inhibitors (CNIs). It aims for complete clinical and immunological remission, and cessation of CNI dependence.
Methods: Thirty-six patients were enrolled in the study with two groups: drug-dependent and partial remission or immune non-remission group.
High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis.
Front Immunol
January 2025
Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital, Olomouc, Czechia.
Introduction: Glucocorticoids (GCs) are widely used as a treatment for rheumatoid arthritis (RA), leading to high cumulative doses in long-term treated patients. The impact of a high cumulative GC dose on the systemic inflammatory response in RA remains poorly understood.
Methods: We investigated long-treated patients with RA (n = 72, median disease duration 14 years) through blood counts and the serum levels of 92 inflammation-related proteins, and disease activity was assessed using the Simple Disease Activity Index (SDAI).
Validation of the World Health Organization's Disability Assessment Schedule 2.0 for children with mental disorders in specialized health-care services.
Front Psychiatry
December 2024
Direction of Epidemiological and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
Introduction: Mental disorders are highly prevalent among children, yet access to timely and effective treatment remains limited. Untreated or poorly managed mental disorders in children are associated with significant functional deterioration and long-term consequences. The validation of reliable assessment tools is crucial for identifying functional impairments and guiding interventions in this population.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!